Zairen Sun

Zairen has over 20 years of experience in the biotechnology industry. He founded Vigene Biosciences in 2012 with the focus of aiding research to cure human diseases through gene therapy and cell therapy. Prior to founding Vigene Biosciences, Zairen was the head of R&D at OriGene Technologies Inc. During his 14-year tenure at OriGene, Zairen and his team created the most comprehensive collection of human full-length cDNA clones and their derivative products like proteins and antibodies. Zairen has many patents and publications. He holds a Ph.D. degree in molecular biology from the University of Maryland at College Park.